title: Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line.
abstract: Esophageal adenocarcinoma currently has one of the most rapidly increasing tumor incidences in the United States, with the vast majority of cases occurring on the backdrop of metaplastic epithelium (Barrett esophagus). The availability of appropriate cell line models is essential for maintaining the pace of esophageal cancer research and for pre-clinical validation of new therapeutic modalities. The identity of several of the widely utilized esophageal adenocarcinoma cell lines (BIC-1, SEG-1 and TE-7) have recently been called into question. Here we describe the establishment and characterization of a bona fide esophageal cancer cell line, JH-EsoAd1, from a patient with Barrett-associated adenocarcinoma. The rapid dissemination of this cancer cell line to the esophageal cancer research community should help ameliorate the current scarcity of preclinical models in this disease.
authors.affiliation: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
authors.forename: Hector
authors.initials: H
authors.lastname: Alvarez
authors.forename: Jan-Bart M
authors.initials: JB
authors.lastname: Koorstra
authors.forename: Seung-Mo
authors.initials: SM
authors.lastname: Hong
authors.forename: Jurjen J
authors.initials: JJ
authors.lastname: Boonstra
authors.forename: Winand N M
authors.initials: WN
authors.lastname: Dinjens
authors.forename: Arlene A
authors.initials: AA
authors.lastname: Foratiere
authors.forename: Tsung-Teh
authors.initials: TT
authors.lastname: Wu
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Montgomery
authors.forename: James R
authors.initials: JR
authors.lastname: Eshleman
authors.forename: Anirban
authors.initials: A
authors.lastname: Maitra
mesh_terms: D000230:Adenocarcinoma / Q000150:complications* / Q000473:pathology; D000368:Aged; D000818:Animals; D001471:Barrett Esophagus / Q000150:complications* / Q000473:pathology; D045744:Cell Line, Tumor; D004938:Esophageal Neoplasms / Q000150:complications / Q000473:pathology; D006801:Humans; D016130:Immunophenotyping; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D008858:Microscopy, Phase-Contrast / Q000379:methods; D009368:Neoplasm Transplantation; D014746:Vimentin / Q000096:biosynthesis
chemical_list: D014746:Vimentin
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10578-82
references.pmid: 1359541
references.citation: Cancer Cell. 2005 May;7(5):469-83
references.pmid: 15894267
references.citation: Cancer Res. 2007 Sep 1;67(17):7996-8001
references.pmid: 17804709
references.citation: Br J Cancer. 1997;75(2):258-63
references.pmid: 9010035
references.citation: Science. 2007 Feb 16;315(5814):928-31
references.pmid: 17303729
references.citation: Br J Cancer. 2007 May 21;96(10):1579-86
references.pmid: 17426708
references.citation: J Surg Res. 2000 Feb;88(2):120-4
references.pmid: 10644476
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: J Pathol. 1994 Jan;172(1):5-12
references.pmid: 7931827
references.citation: Cancer Res. 1984 Dec;44(12 Pt 1):5813-21
references.pmid: 6498841
references.citation: Science. 1992 May 1;256(5057):668-70
references.pmid: 1350108
references.citation: J Thorac Cardiovasc Surg. 2007 Mar;133(3):763-9
references.pmid: 17320581
references.citation: Nat Rev Mol Cell Biol. 2000 Dec;1(3):233-6
references.pmid: 11252900
references.citation: Cancer Cell. 2004 Jul;6(1):11-6
references.pmid: 15261138